Osteopontin as a Regulator of Colorectal Cancer Progression and Its Clinical Applications
A high expression of the phosphoprotein osteopontin (OPN) has been associated with cancer progression in several tumor types, including breast cancer, hepatocarcinoma, ovarian cancer, and colorectal cancer (CRC). Interestingly, OPN is overexpressed in CRC and is associated with a poor prognosis link...
Main Authors: | Katyana Amilca-Seba, Michèle Sabbah, Annette K. Larsen, Jérôme A. Denis |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/15/3793 |
Similar Items
-
Osteopontin (OPN/SPP1), a Mediator of Tumor Progression, Is Regulated by the Mesenchymal Transcription Factor Slug/SNAI2 in Colorectal Cancer (CRC)
by: Katyana Amilca-Seba, et al.
Published: (2022-05-01) -
The Role and Clinical Relevance of Osteopontin in Allergic Airway Diseases
by: Yang Liu, et al.
Published: (2023-03-01) -
Expression of Spermine Oxidase Is Associated with Colorectal Carcinogenesis and Prognosis of Patients
by: Sooyoun Kim, et al.
Published: (2022-03-01) -
Osteopontin in Cancer: Mechanisms and Therapeutic Targets
by: Yoshinobu Kariya, et al.
Published: (2022-08-01) -
Osteopontin as a Biomarker in Chronic Kidney Disease
by: Satyesh K. Sinha, et al.
Published: (2023-05-01)